EUVIMEDEUVIMED entdecken
Crossref

Association between gut microbiota and disorders of lipoprotein metabolism: a two sample Mendelian randomization study

Qingyao Du, Yiqing Chen, Changhan Kou, Jirui Wei, Ruiquan Xu, Yingwen Cao, Lin Yu, Xiaoxia Kou

Nutrition, Metabolism and Cardiovascular Diseases · 2025

DOI: 10.1016/j.numecd.2025.104212 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2025. Verfasst von Qingyao Du und 7 weiteren Autor:innen. Beteiligte Einrichtung: Guangzhou Key Laboratory for Clinical Rapid Diagnosis and Early Warning of Infectious Diseases, KingMed School of Laboratory Medicine, Guangzhou Medi…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Lipoproteins, Dyslipidemias, Bacteria. Die Arbeit nennt 54 Literaturangaben. Gefördert von: Guangdong Provincial Natural Science Foundation, Guangzhou Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIM: Hyperlipidemia is a major risk factor for cardiovascular diseases, but its relationship with gut microbiota remains unclear. This study aimed to systematically assess genetic associations between gut microbiota and lipoprotein metabolism disorders using Mendelian randomization (MR) and explore their links with cardio-metabolic risk factors such as obesity, diabetes and BMI. METHODS AND RESULTS: We performed a two-sample MR analysis integrating gut microbiota GWAS data from the MiBioGen consortium (n = 18,340) and lipoprotein metabolism disorder data from FinnGen (14,101 cases/197,259 controls). Inverse variance weighted (IVW) analysis identified five protective taxa, including Lachnoclostridium (OR = 0.748) and an unknown genus (id.826; OR = 0.789), and four risk taxa such as Actinobacteria (OR = 1.226) and Ruminiclostridium5 (OR = 1.227). Cross-phenotype analyses revealed consistent protective effects: Lachnoclostridium abundance inversely correlated with BMI (OR = 0.942), while the unknown genus (id.826) was protective against diabetes (OR = 0.874). Sensitivity analyses confirmed robustness (no heterogeneity or horizontal pleiotropy). CONCLUSIONS: This study reveals the complex role of gut microbiota in metabolic diseases through MR, and its effects may depend on the host's metabolic status. The results provide a theoretical basis for precise intervention strategies targeting microbial communities, and in the future, it is necessary to combine multi omics and experimental models to validate key microbial communities and their mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeLipoproteinsDyslipidemiasBacteriaHyperlipidemiasHumansMendelian Randomization AnalysisGenetic Predisposition to DiseaseRisk AssessmentGenome-Wide Association StudyPhenotypeMaleFemaleObesity

Stichwörter der Autor:innen

Cardiometabolic risk factorsDisorders of lipoprotein metabolismGut microbiotaHyperlipidemiaMendelian randomization study

Substanzen

Lipoproteins

Autor:innen und Institutionen

  • Guangzhou Key Laboratory for Clinical Rapid Diagnosis and Early Warning of Infectious Diseases, KingMed School of Laboratory Medicine, Guangzhou Medical University, Guangzhou, 510180, China; Microbiome Medicine Center,…
  • Guangzhou Key Laboratory for Clinical Rapid Diagnosis and Early Warning of Infectious Diseases, KingMed School of Laboratory Medicine, Guangzhou Medical University, Guangzhou, 510180, China.
  • Basic Medicine, Hubei University of Science and Technology School, Xianning, 437100, China.
  • Microbiome Medicine Center, Department of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, China.
  • Guangzhou Key Laboratory for Clinical Rapid Diagnosis and Early Warning of Infectious Diseases, KingMed School of Laboratory Medicine, Guangzhou Medical University, Guangzhou, 510180, China; Department of Clinical Labor…
  • Guangzhou Key Laboratory for Clinical Rapid Diagnosis and Early Warning of Infectious Diseases, KingMed School of Laboratory Medicine, Guangzhou Medical University, Guangzhou, 510180, China. Electronic address: kouxiaox…

Förderung

  • Guangdong Provincial Natural Science Foundation
  • Guangzhou Medical University

Zitieren

APA

Du, Q., Chen, Y., Kou, C., Wei, J., Xu, R., Cao, Y., Yu, L., & Kou, X. (2025). Association between gut microbiota and disorders of lipoprotein metabolism: a two sample Mendelian randomization study. Nutrition, Metabolism and Cardiovascular Diseases. https://doi.org/10.1016/j.numecd.2025.104212

Vancouver

Du Q, Chen Y, Kou C, Wei J, Xu R, Cao Y, et al. Association between gut microbiota and disorders of lipoprotein metabolism: a two sample Mendelian randomization study. Nutrition, Metabolism and Cardiovascular Diseases. 2025. doi:10.1016/j.numecd.2025.104212

BibTeX
@article{Du2025,
  author = {Du, Qingyao and Chen, Yiqing and Kou, Changhan and Wei, Jirui and Xu, Ruiquan and Cao, Yingwen and Yu, Lin and Kou, Xiaoxia},
  title = {Association between gut microbiota and disorders of lipoprotein metabolism: a two sample Mendelian randomization study},
  journal = {Nutrition, Metabolism and Cardiovascular Diseases},
  year = {2025},
  doi = {10.1016/j.numecd.2025.104212}
}
Kostenlos starten →